Skip to end of banner
Go to start of banner

Study Organization and Documentation

Skip to end of metadata
Go to start of metadata

You are viewing an old version of this page. View the current version.

Compare with Current View Page History

« Previous Version 13 Next »

TEAM REVIEW All teams should review and agree on study conventions.

Study Naming

MODEL-AD data and metadata are organized by site and study.

Study type

How many strains?

Naming convention

Example names

Primary screen

Many

Site_PrimaryScreen

  • Jax.IU.Pitt_PrimaryScreen

  • UCI_PrimaryScreen

Strain validation

Many

Site_StrainValidation

  • Jax.IU.Pitt_StrainValidation

  • UCI_StrainValidation

Deep phenotyping

One

Site_Model

  • Jax.IU.Pitt_APOE4_Trem2

  • UCI_5XFAD

Pharmacokinetic (PK)

One

Site_Model_Drug

  • Jax.IU.Pitt_5XFAD_Verubecestat

Pilot Studies

  • Microbiome

  • Proteomics and Metabolomics

Many

Site_StudyType_Pilot

  • Jax.IU.Pitt_MicrobiomePilot Link

  • Jax.IU.Pitt.Proteomics_Metabolomics_Pilot Link

Study Description

Each study should be accompanied by a brief study description that includes the species, genetic background, a link to the Jax Datasheet (if available) or a description of how the animals were created.

Download the in-progress study description template.

Assay Description

Each assessment should be accompanied by a brief description with information about the assessment procedures, data generation and processing, and analytical methods. This information is often described in the Materials and Methods section of a manuscript. This is a good opportunity to clarify or provide additional detail that may not be included in the peer-reviewed manuscript.

TODO A methods description template will be made available here.

Issues to clarify include:

  • File naming conventions

  • Assay-specific examples. Need a list of most common assays.

    • RNA sequencing

    • Behavioral

    • Frailty

    • Open field

Study Organization

MODEL-AD Studies will be organized in Synapse with a directory schema similar to this:

  • Study_name/

    • Assay_Type_1/ (data from first assay)

    • Assay_Type_2/ (data from second assay)

    • Metadata/

    • Staging/ (data that has yet to be released)

      • Assay_Type_n/ (unreleased data from nth assay)

Acknowledgement Statement

Every MODEL-AD study should include the following acknowledgment:

The results published here are in whole or in part based on data obtained from the AD Knowledge Portal ( https://adknowledgeportal.synapse.org/ ). The IU/JAX/UCI MODEL-AD Center was established with funding from The National Institute on Aging (U54 AG054345-01 and AG054349). Aging studies are also supported by the Nathan Shock Center of Excellence in the Basic Biology of Aging (NIH P30 AG0380770).

  • No labels

0 Comments

You are not logged in. Any changes you make will be marked as anonymous. You may want to Log In if you already have an account.